{{Rsnum
|rsid=7770731
|Chromosome=6
|position=14598589
|Orientation=plus
|GMAF=0.2525
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=RP11-330A16.1
|Gene_s=RP11-330A16.1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 31.9 | 65.5
| HCB | 4.5 | 22.6 | 72.9
| JPT | 1.8 | 27.4 | 70.8
| YRI | 28.3 | 49.7 | 22.1
| ASW | 15.8 | 59.6 | 24.6
| CHB | 4.5 | 22.6 | 72.9
| CHD | 5.6 | 30.6 | 63.9
| GIH | 20.8 | 56.4 | 22.8
| LWK | 32.1 | 38.5 | 29.4
| MEX | 5.2 | 29.3 | 65.5
| MKK | 14.3 | 44.2 | 41.6
| TSI | 5.9 | 27.7 | 66.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=0.000001
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}